HERZUMA
Live / Registered — Registered (as of 21 Apr 2026)
What this means for you
Registered since 21 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Apr 2032: the §71 affidavit of use).
Record
- Serial number
- 79429288
- Registration number
- 8217584
- Mark type
- Design + words
- Filed
- 27 Jun 2025
- Published for opposition
- 03 Mar 2026
- Registered
- 21 Apr 2026
- Next maintenance filing
- §71 affidavit of use, due by 21 Apr 2032 (grace period to 21 Oct 2032)
- Attorney of record
- Kisuk LEE
Goods and services
- Class 005 — Pharmaceuticals: anti-cancer preparations; pharmaceutical products for the treatment of cancer; diagnostic test reagents for medical purposes; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for the treatment of auto-immune diseases; diagnostic preparations for medical purposes; pharmaceutical products for treating respiratory diseases.
Owner
- CELLTRION, INC., KR
- CELLTRION, INC., KR
- CELLTRION, INC., KR
Prosecution history
- 15 Oct 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Sept 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Sept 2026 — FINAL DISPOSITION PROCESSED
- 21 Jul 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 26 Feb 2026 — NOTIFICATION PROCESSED BY IB
- 25 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 10 Feb 2026 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 04 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE